The impact of antibiotic use on resistance development and persistence

Drug Resistance Updates

Volumn 3, Issue 5, 2000, Pages 303-311

  Barbosa, Teresa M ^a   Levy, Stuart B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; DRUG MISUSE; DRUG SENSITIVITY; DRUG USE; HEREDITY; HUMAN; INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS;

EID: 0033653688     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0167     Document Type: Article

References (72)

1. Estimating worldwide current antibiotic usage: Report of Task Force I
2. Report of the ASM task force on antibiotic resistance
3. The antibiotic paradox
4. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB
5. Conjugative plasmids in bacteria of the 'pre-antibiotic' era
6. The challenge of antibiotic resistance
7. Antibacterial use in community practice: Assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance
8. Antibiotic resistance: An ecological imbalance
9. Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies
10. Balancing the drug-resistance equation
11. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
12. An antibiotic policy to prevent emergence of resistant bacilli
13. Low dosage and long treatment duration of β-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
14. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children
15. Emergence and spread of antibiotic-resistant S. pneumoniae
16. Bacterial drug resistance: Response to survival threats
17. Genetic mobility and distribution of tetracycline resistance determinants
18. Antibiotic resistance in gram-negative bacteria: The role of gene cassetes and integrons
19. Antimicrobial resistance in hospital organisms and its relation to antibiotic use
20. Antibiotic resistance in Spain: What can be done? Task force of the general direction for health planning of the spanish ministry of health
21. Outpatient use of erythromycin: Link to increased erythromycin resistance in group A streptococci
22. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
23. Increasing resistance to fluroquinolones in Escherichia coli from urinary tract infections in The Netherlands
24. Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico
25. High frequency of antimicrobial resistance in human fecal flora
26. Pneumococcal resistance patterns in Europe
27. Antibiotic usage in animals: Impact on bacterial resistance and public health
28. Evolution of a bacteria/plasmid association
29. Epidemic in cattle and humans of Salmonella typhimurium DT104 with chromosomally integrated multiple drug resistance
30. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine
31. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998
32. Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut
33. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
34. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage
35. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
36. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community
37. The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production
38. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms
39. Animal feed antibiotic use raises drug resistance fear
40. Antibiotic use in plant disease control
41. Determination of neomycin residues in eggs and stability of residues after cooking
42. Microbial resistance to antibiotics. An evolving and persistent problem
43. Drugged waters: Does it matter that pharmaceuticals are turning up in water supplies?
44. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
45. A review of the role of antibiotic policies in the control of antibiotic resistance
46. Reversal of antibiotic resistance in hospital Staphylococcal infection
47. Control of infection clue to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics
48. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital
49. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes
50. Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
51. Decreased antimicrobial resistance after changes in antibiotic use
52. Decline of erythromycin resistance of group A streptococci in Japan
53. Epidemiology of penicillin resistant pneumococci in Iceland-Hope for the future?
54. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
55. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry
56. The effect of banning avoparcin on VRE carriage in The Netherlands
57. Antibiotic resistance found in wild rodents
58. Antibiotic resistance from food
59. Acquired antibiotic resistance in lactic acid bacteria from food
60. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
61. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
62. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness
63. The cost of antibiotic resistance from a bacterial prespective
64. Role of Fem factors in methicillin resistance
65. Two types of Bacillus subtilis tetA(L) deletion strains reveal the physiological importance of TetA(L) in K(+) acquisition as well as in Na(+), alkali, and tetracycline resistance
66. Mercury released from dental 'silver' fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates
67. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
68. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: Roles of the mar and acrAB loci
69. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: Application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems
70. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli